Drugs / EB070
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07413536 | Mar → Dec 2026 expected | — | Biotech Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EB070 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07413536 ↗ |
| Route | Subcutaneous | “Receive a single subcutaneous injection of EB070 or placebo” NCT07413536 ↗ |